Fractyl Health (GUTS) vs PAVmed (PAVM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
PAVmed (PAVM) has outperformed Fractyl Health (GUTS) over the past year, losing 88.8% versus a loss of 95.1%. Fractyl Health is the larger company by market cap ($10.9 million vs $9.1 million), about 1.2 times the size, while PAVmed is growing revenue faster (-97.6% vs -100.0%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GUTS | PAVM |
|---|---|---|
| Share price | $0.82 | $1.14 |
| Market cap | $10.88M | $9.08M |
| 1-day change | -14.16% | -5.42% |
| YTD return | -96.89% | -82.88% |
| 1-year return | -95.12% | -88.77% |
| 5-year return | — | -99.93% |
| EPS (TTM) | $-3.14 | $-7.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $0 | $71.00K |
| Revenue growth (YoY) | -100.00% | -97.63% |
| Net income (latest FY) | $-140.95M | $401.00K |
| Gross margin | — | -207.04% |
| Operating margin | — | -30712.68% |
| Net margin | — | 564.79% |
| 52-week high | $29.34 | $28.44 |
| 52-week low | $0.784 | $1.10 |
| Distance from 52-week high | -97.21% | -96.01% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +7265.85% | +3115.86% |
| Average volume | 504.39K | 23.70K |
| Shares outstanding | 13.26M | 8.00M |
| Employees | 100 | 41 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Fractyl Health
GUTS stock →Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
Health Care · Medical/Dental Instruments · 100 employees
About PAVmed
PAVM stock →PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.
Health Care · Medical/Dental Instruments · 41 employees
GUTS vs PAVM FAQ
Which is bigger, Fractyl Health or PAVmed?
Fractyl Health (GUTS) is larger, with a market capitalization of $10.88M compared with $9.08M for PAVmed (PAVM).
Which stock has performed better over the past year, GUTS or PAVM?
PAVM returned -88.77% over the past 12 months, compared with -95.12% for GUTS (price return, excluding dividends). Past performance does not predict future results.
Are Fractyl Health and PAVmed in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.